Other Financial Information

9 Months Ended

Sep. 30, 2021

Other Financial Information [Abstract]

Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consist of the following (in thousands):


	September 30, 2021		December 31, 2020
Diagnostic testing supplies	$	1,010	$	1,203
Prepaid product royalties	54		68
Prepaid maintenance and insurance contracts	1,040		2,229
Other prepaid and other current assets	301		659
Prepaid and other current assets	$	2,405	$	4,159

Property and Equipment

Property and equipment consist of the following (in thousands):


	September 30, 2021		December 31, 2020
Furniture and fixtures	$	83	$	64
Laboratory equipment	4,100		2,679
Computer equipment and software	1,106		927
Leasehold improvements	1,141		1,072
Construction in progress	613		301
Total property and equipment	7,043		5,043
Less: accumulated depreciation and amortization	(3,597)		(2,941)
Property and equipment, net	$	3,446	$	2,102

Depreciation and amortization expense for the three months ended September 30, 2021 and 2020 was approximately $0.3 million and $0.1 million, and for the nine months ended September 30, 2021 and 2020, was approximately $0.7 million and $0.4 million, respectively. At September 30, 2021 and December 31, 2020, the gross book value of assets under capital lease was $2.5 million and $1.2 million, respectively, and is classified in "Laboratory equipment" in the table above.

Accrued and Other Current Liabilities

Accrued and other current liabilities consist of the following (in thousands):


	September 30, 2021		December 31, 2020
Accrued payroll and related expenses	$	3,793	$	3,589

Accrued interest	145		147
Accrued purchases of goods and services	765		311
Accrued royalties	342		221
Accrued clinical study activity	337		228
Capital lease obligations, current portion	586		308
Other accrued liabilities	616		953
Accrued and other current liabilities	$	6,584	$	5,757